Michael Adelman

Michael Adelman is a declared insider of Aptevo Therapeutics Inc., with filings sourced from SEC (Form 4). We count 2 filings, every one of them for a trade on 1 March 2019.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 4 March 2019, reports an option exercise in Aptevo Therapeutics Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.